HRP20110468T1 - 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata za uporabu u liječenju miokardijalne infarkcije - Google Patents

3-(2,2,2-trimetilhidrazinij) sol na bazi propionata za uporabu u liječenju miokardijalne infarkcije Download PDF

Info

Publication number
HRP20110468T1
HRP20110468T1 HR20110468T HRP20110468T HRP20110468T1 HR P20110468 T1 HRP20110468 T1 HR P20110468T1 HR 20110468 T HR20110468 T HR 20110468T HR P20110468 T HRP20110468 T HR P20110468T HR P20110468 T1 HRP20110468 T1 HR P20110468T1
Authority
HR
Croatia
Prior art keywords
trimethylhydrazinium
myocardial infarction
propionate
treating myocardial
propionate salts
Prior art date
Application number
HR20110468T
Other languages
English (en)
Inventor
Kalvins Ivars
Stonans Ilmars
Vilskersts Reinis
Liepins Edgars
Dambrova Maija
Birmans Anatolijs
Original Assignee
Grindeks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40364183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110468(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks filed Critical Grindeks
Publication of HRP20110468T1 publication Critical patent/HRP20110468T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Uporaba 3-(2,2,2-trimetilhidrazinij) soli na bazi propionata koja je izabrana iz skupine koja se sastoji od dihidrogen fosfata i hidrogen fumarata za proizvodnju lijeka za liječenje miokardijalne infarkcije. Patent sadrži još 3 patentna zahtjeva.

Claims (4)

1. Uporaba 3-(2,2,2-trimetilhidrazinij) soli na bazi propionata koja je izabrana iz skupine koja se sastoji od dihidrogen fosfata i hidrogen fumarata za proizvodnju lijeka za liječenje miokardijalne infarkcije.
2. Uporaba prema patentnom zahtjevu 1, gdje je 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata 3-(2,2,2-trimetilhidrazinij) propionat hidrogen fumarat.
3. Uporaba prema patentnom zahtjevu 1, gdje je 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata 3-(2,2,2-trimetilhidrazinij) propionat dihidrogen fosfat.
4. 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata koja je izabrana iz skupine koja se sastoji od dihidrogen fosfata i hidrogen fumarata za uporabu u liječenju miokardijalne infarkcije.
HR20110468T 2007-12-05 2011-06-21 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata za uporabu u liječenju miokardijalne infarkcije HRP20110468T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122360 2007-12-05
EP07122359 2007-12-05
PCT/EP2008/066712 WO2009071586A2 (en) 2007-12-05 2008-12-03 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease

Publications (1)

Publication Number Publication Date
HRP20110468T1 true HRP20110468T1 (hr) 2011-08-31

Family

ID=40364183

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110468T HRP20110468T1 (hr) 2007-12-05 2011-06-21 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata za uporabu u liječenju miokardijalne infarkcije

Country Status (36)

Country Link
US (1) US20110028438A1 (hr)
EP (1) EP2222376B1 (hr)
JP (1) JP2011506285A (hr)
KR (1) KR20100084687A (hr)
CN (1) CN101951991A (hr)
AR (1) AR069548A1 (hr)
AT (1) ATE503473T1 (hr)
AU (1) AU2008333263A1 (hr)
BR (1) BRPI0819055A2 (hr)
CA (1) CA2706357C (hr)
CL (1) CL2008003552A1 (hr)
CO (1) CO6280507A2 (hr)
DE (1) DE602008005930D1 (hr)
DK (1) DK2222376T3 (hr)
DO (1) DOP2010000162A (hr)
EA (1) EA016971B1 (hr)
GE (1) GEP20125646B (hr)
HR (1) HRP20110468T1 (hr)
IL (1) IL205962A0 (hr)
MA (1) MA31992B1 (hr)
MX (1) MX2010006257A (hr)
MY (1) MY158799A (hr)
NZ (1) NZ586518A (hr)
PA (1) PA8806001A1 (hr)
PE (1) PE20091209A1 (hr)
PL (1) PL2222376T3 (hr)
PT (1) PT2222376E (hr)
RS (1) RS51785B (hr)
SI (1) SI2222376T1 (hr)
SV (1) SV2010003585A (hr)
TN (1) TN2010000249A1 (hr)
TW (1) TWI391131B (hr)
UA (1) UA100249C2 (hr)
UY (1) UY31499A1 (hr)
WO (1) WO2009071586A2 (hr)
ZA (1) ZA201003640B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012247467B2 (en) * 2011-04-27 2016-07-28 Grindeks, A Joint Stock Company Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
RU2457198C1 (ru) * 2011-05-31 2012-07-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13280B (en) * 2003-08-04 2005-11-20 Grindeks Publiska As Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof
ATE386014T1 (de) * 2003-08-04 2008-03-15 Grindeks Jsc Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
WO2009071586A3 (en) 2009-09-24
CL2008003552A1 (es) 2009-12-18
IL205962A0 (en) 2010-11-30
ATE503473T1 (de) 2011-04-15
ZA201003640B (en) 2011-03-30
US20110028438A1 (en) 2011-02-03
DOP2010000162A (es) 2010-08-31
PA8806001A1 (es) 2009-08-26
EA016971B1 (ru) 2012-08-30
NZ586518A (en) 2012-02-24
TW200927092A (en) 2009-07-01
AR069548A1 (es) 2010-02-03
DK2222376T3 (da) 2011-07-25
CO6280507A2 (es) 2011-05-20
EP2222376A2 (en) 2010-09-01
TN2010000249A1 (en) 2011-11-11
JP2011506285A (ja) 2011-03-03
SV2010003585A (es) 2011-03-23
EA201000739A1 (ru) 2011-02-28
PE20091209A1 (es) 2009-09-10
CA2706357A1 (en) 2009-06-11
AU2008333263A1 (en) 2009-06-11
SI2222376T1 (sl) 2011-08-31
UA100249C2 (uk) 2012-12-10
MA31992B1 (fr) 2011-01-03
RS51785B (en) 2011-12-31
PL2222376T3 (pl) 2011-10-31
MX2010006257A (es) 2010-08-10
DE602008005930D1 (de) 2011-05-12
EP2222376B1 (en) 2011-03-30
GEP20125646B (en) 2012-09-25
KR20100084687A (ko) 2010-07-27
MY158799A (en) 2016-11-15
WO2009071586A2 (en) 2009-06-11
UY31499A1 (es) 2009-01-30
CA2706357C (en) 2013-06-11
PT2222376E (pt) 2011-07-01
CN101951991A (zh) 2011-01-19
BRPI0819055A2 (pt) 2015-05-05
TWI391131B (zh) 2013-04-01

Similar Documents

Publication Publication Date Title
EA201201648A1 (ru) Стимуляторы sgc
RS53096B (en) OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
AU2018236805B2 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
HN2011001446A (es) Compuesto utiles para inhibir chk1
RS52102B (en) PIRPHENIDONE THERAPY Avoiding FLUVOXAMINE
MY168425A (en) New coated controlled release active agent carriers
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NZ601350A (en) Method of treating arthritis
TNSN08443A1 (en) Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
MY169980A (en) Bisaryl-linked aryltriazolones and their use
MY156777A (en) Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof
GT201200164A (es) "nuevos compuestos de espiropiperidina"
ATE554089T1 (de) Spirocyclische cyclohexan-derivate
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
CR20110403A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
NZ582284A (en) Carbamoyl-cyclohexanes for treating acute mania
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
SV2010003770A (es) Composicion y proceso- 356
TN2014000141A1 (en) New coated controlled release active agent carriers
HRP20110468T1 (hr) 3-(2,2,2-trimetilhidrazinij) sol na bazi propionata za uporabu u liječenju miokardijalne infarkcije
PE20140337A1 (es) Nuevas formas cristalinas de la sal sodica del acido (4-{4-[5-(6-trifluoro-metil-piridin-3-il-amino)-piridin-2-il]-fenil}-ciclhexil)-acetico
MY148732A (en) Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
HRP20110744T1 (hr) Medicinska uporaba 3-(2,2,2-trimetilhidrazin)propionat hidrogen fumarata i dihidrogen fosfata